English
Insider transactions
EDGARAEON Biopharma, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-16.
- Open-market purchases (code P)
- 1 transactions, 1,150,000 shares
- Sum of shares × price per share: 243,455
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–17 of 17
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-30 Filed 2026-11-10 | Daewoong Co., Ltd 10% owner | XExercise of in-the-money or at-the-money derivative security | Acquired (A) | 11,236,631 | 0.0001 | 1,123.6631Derived: shares × price per share. Exact value 1123.6631. | 23,188,345 | Indirect (I) By Daewoong Pharmaceutical Co., Ltd. | No | F2, F1
| Open filing 0001213900-26-117865 Read from the filing’s XML Dispute this row |
| 2026-10-30 Filed 2026-11-10 | Daewoong Co., Ltd 10% owner | JOther acquisition or disposition (describe transaction) | Disposed (D) | 3,822 | 0.294 | 1,123.668Derived: shares × price per share. Exact value 1123.668. | 23,184,523 | Indirect (I) By Daewoong Pharmaceutical Co., Ltd. | No | F3, F1
| Open filing 0001213900-26-117865 Read from the filing’s XML Dispute this row |
| 2026-10-30 Filed 2026-11-10 | Daewoong Co., Ltd 10% owner | XExercise of in-the-money or at-the-money derivative security | Disposed (D) | 11,236,631 | 0 | — | 0 | Indirect (I) By Daewoong Pharmaceutical Co., Ltd. | No | F2, F4, F1
| Open filing 0001213900-26-117865 Read from the filing’s XML Dispute this row |
| 2026-08-19 Filed 2026-08-21 | LYNCH TIMOTHY P 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,150,000 | 0.2117 | 243,455Derived: shares × price per share. Exact value 243455.0000. | 6,500,000 | Direct (D) | No | F1
| Open filing 0000935836-26-000440 Read from the filing’s XML Dispute this row |
| 2026-06-17 Filed 2026-06-22 | Carter Eric G Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 222,684 | 0 | — | 258,705 | Direct (D) | No | F1
| Open filing 0001104659-26-076509 Read from the filing’s XML Dispute this row |
| 2026-06-17 Filed 2026-06-22 | Forth Marc Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 222,684 | 0 | — | 973,231 | Direct (D) | No | F1
| Open filing 0001104659-26-076511 Read from the filing’s XML Dispute this row |
| 2026-06-17 Filed 2026-06-22 | FISCHER JOST Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 222,684 | 0 | — | 489,469 | Direct (D) | No | F1
| Open filing 0001104659-26-076510 Read from the filing’s XML Dispute this row |
| 2026-06-17 Filed 2026-06-22 | Thunen Shelley B Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 222,684 | 0 | — | 258,705 | Direct (D) | No | F1
| Open filing 0001104659-26-076515 Read from the filing’s XML Dispute this row |
| 2026-06-17 Filed 2026-06-22 | PALMISANO ROBERT J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 222,684 | 0 | — | 258,705 | Direct (D) | No | F1
| Open filing 0001104659-26-076513 Read from the filing’s XML Dispute this row |
| 2026-04-02 Filed 2026-04-03 | Bencich John Officer: CHIEF FINANCIAL OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 754,717 | 0 | — | 754,717 | Direct (D) | No | F1
| Open filing 0001104659-26-039697 Read from the filing’s XML Dispute this row |
| 2026-03-04 Filed 2026-03-11 | Oh Chad Officer: CHIEF MEDICAL OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 1,316,872 | 0 | — | 2,183,436 | Direct (D) | No | F2
| Open filing 0001104659-26-026550 Read from the filing’s XML Dispute this row |
| 2026-03-04 Filed 2026-03-05 | Sy Jennifer Officer: PRINCIPAL ACCOUNTING OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 925,925 | 0 | — | 1,501,176 | Direct (D) | No | F2
| Open filing 0001104659-26-024231 Read from the filing’s XML Dispute this row |
| 2026-03-04 Filed 2026-03-05 | Wilson Alexander Blair Officer: CLO, CSO, and Corp Secretary | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 1,316,872 | 0 | — | 2,183,005 | Direct (D) | No | F2
| Open filing 0001104659-26-024233 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-03-11 | Oh Chad Officer: CHIEF MEDICAL OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 862,500 | 0 | — | 866,564 | Direct (D) | No | F1
| Open filing 0001104659-26-026550 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-03-05 | Sy Jennifer Officer: PRINCIPAL ACCOUNTING OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 575,000 | 0 | — | 575,251 | Direct (D) | No | F1
| Open filing 0001104659-26-024231 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-03-05 | Wilson Alexander Blair Officer: CLO, CSO, and Corp Secretary | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 862,500 | 0 | — | 866,133 | Direct (D) | No | F1
| Open filing 0001104659-26-024233 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-02-19 | Bancroft Robert E. Director · Officer: PRESIDENT CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,000,000 | 0 | — | 3,177,103 | Direct (D) | No | F1
| Open filing 0001104659-26-017726 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,150 filings read.
Showing 1–21 of 21
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 4,400,000 SH | 1,297,780 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-127125 Filed 2026-11-13 Dispute this row |
| Stonepine Capital Management, LLC | 2,125,748 SH | 637,724 dollars | Not in the prior quarter’s filings read | Open filing 0001440771-26-000027 Filed 2026-11-13 Dispute this row |
| DG Capital Management, LLC | 259,146 SH | 77,744 dollars | Not in the prior quarter’s filings read | Open filing 0001512716-26-000017 Filed 2026-11-12 Dispute this row |
| JANE STREET GROUP, LLC Partly reported under another manager | 249,762 SH | 74,928 dollars | Not in the prior quarter’s filings read | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 214,725 SH | 64,418 dollars | Higher by 201,012 Prior quarter: 13,713 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 95,311 SH | 28,592 dollars | Unchanged Prior quarter: 95,311 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 90,529 SH | 27,159 dollars | Unchanged Prior quarter: 90,529 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| Blue Owl Capital Holdings LP Partly reported under another manager | 42,353 SH | 12,706 dollars | Unchanged Prior quarter: 42,353 | Open filing 0001193125-26-459653 Filed 2026-11-13 Dispute this row |
| Formidable Asset Management, LLC | 20,024 SH | 14,403 dollars | Unchanged Prior quarter: 20,024 | Open filing 0001592613-26-000009 Filed 2026-11-03 Dispute this row |
| Beacon Wealthcare LLC Partly reported under another manager | 12,856 SH | 3,857 dollars | Not in the prior quarter’s filings read | Open filing 0001849336-26-000005 Filed 2026-10-02 Dispute this row |
| LPL Financial LLC | 11,500 SH | 3,450 dollars | Lower by 7 Prior quarter: 11,507 | Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 2,834 SH | 850 dollars | Unchanged Prior quarter: 2,834 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| Steward Partners Investment Advisory, LLC | 1,100 SH | 330 dollars | Unchanged Prior quarter: 1,100 | Open filing 0001723397-26-000006 Filed 2026-11-13 Dispute this row |
| WOLFF WIESE MAGANA LLC | 567 SH | 171 dollars | Unchanged Prior quarter: 567 | Open filing 0001832097-26-000005 Filed 2026-10-15 Dispute this row |
| SBI Securities Co., Ltd. | 329 SH | 99 dollars | Higher by 97 Prior quarter: 232 | Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row |
| DUPONT CAPITAL MANAGEMENT CORP | 170 SH | 51 dollars | Unchanged Prior quarter: 170 | Open filing 0001140361-26-040602 Filed 2026-10-23 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 150 SH | 45 dollars | Unchanged Prior quarter: 150 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| GHP Investment Advisors, Inc. | 95 SH | 29 dollars | Unchanged Prior quarter: 95 | Open filing 0001140361-26-039674 Filed 2026-10-15 Dispute this row |
| BARCLAYS PLC Partly reported under another manager | 1 SH | 0 dollars | Lower by 58 Prior quarter: 59 | Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row |
| Caitong International Asset Management Co., Ltd | 1 SH | 0 dollars | Unchanged Prior quarter: 1 | Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row |
| DANSKE BANK A/S | 1 SH | 0 dollars | Unchanged Prior quarter: 1 | Open filing 0001104659-26-124081 Filed 2026-11-09 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Dauntless Investment Group, LLC 12,490,154 SH
- StoneX Group Inc. 18,953 SH
- CITIGROUP INC 7,315 SH
- UBS Group AG 5,062 SH
- Tower Research Capital LLC (TRC) 2,567 SH
- WELLS FARGO COMPANY/MN 90 SH
- MERCER GLOBAL ADVISORS INC /ADV 80 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Daewoong Co., Ltd. Class A Common Stock, $0.0001 par value per share | 30.6 | 23,242,546.00 | 10/30/2026 Filed 2026-11-10 | SCHEDULE 13D/AAmendment 1 | Open filing 0001213900-26-117881 Dispute this row |
| Daewoong Pharmaceutical Co., Ltd. Class A Common Stock, $0.0001 par value per share | 30.5 | 23,184,523.00 | 10/30/2026 Filed 2026-11-10 | SCHEDULE 13D/AAmendment 1 | Open filing 0001213900-26-117881 Dispute this row |
| Nantahala Capital Management, LLC Class A common stock, $0.0001 par value per share | 9.99 | 5,048,027.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G | Open filing 0001104659-26-127174 Dispute this row |
| Wilmot B. Harkey Class A common stock, $0.0001 par value per share | 9.99 | 5,048,027.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G | Open filing 0001104659-26-127174 Dispute this row |
| Daniel Mack Class A common stock, $0.0001 par value per share | 9.99 | 5,048,027.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G | Open filing 0001104659-26-127174 Dispute this row |
| Timothy P. Lynch Class A Common Stock | 13.0 | 6,500,000 | 08/19/2026 Filed 2026-08-21 | SCHEDULE 13G | Open filing 0000935836-26-000442 Dispute this row |
| Stonepine Capital Management, LLC Class A Common Stock | 9.9 | 6,892,682.00 | 07/15/2026 Filed 2026-07-21 | SCHEDULE 13G | Open filing 0001440771-26-000012 Dispute this row |
| Stonepine Capital, L.P. Class A Common Stock | 9.9 | 6,892,682.00 | 07/15/2026 Filed 2026-07-21 | SCHEDULE 13G | Open filing 0001440771-26-000012 Dispute this row |
| Stonepine GP, LLC Class A Common Stock | 9.9 | 6,892,682.00 | 07/15/2026 Filed 2026-07-21 | SCHEDULE 13G | Open filing 0001440771-26-000012 Dispute this row |
| Jon M. Plexico Class A Common Stock | 9.9 | 6,892,682.00 | 07/15/2026 Filed 2026-07-21 | SCHEDULE 13G | Open filing 0001440771-26-000012 Dispute this row |
| Daewoong Co.,Ltd. ("DWC") Common Stock, $0.0001 par value per share | 49.99 | 12,009,737.00 | 01/21/2026 Filed 2026-01-29 | SCHEDULE 13D | Open filing 0001213900-26-009802 Dispute this row |
| Daewoong Pharmaceutical Co. Ltd ("DWP") Common Stock, $0.0001 par value per share | 49.75 | 12,009,737.00 | 01/21/2026 Filed 2026-01-29 | SCHEDULE 13D | Open filing 0001213900-26-009802 Dispute this row |
| Alta Partners LLC Common Stock | 2.1 | 249,870.00 | 09/30/2025 Filed 2025-10-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001896206-25-000007 Dispute this row |
| Alta Partners LLC Common Stock | 5.1 | 586,335.00 | 06/30/2025 Filed 2025-07-09 | SCHEDULE 13G/AAmendment 1 | Open filing 0002022308-25-000002 Dispute this row |
| Daewoong Co.,Ltd. ("DWC") Common Stock, $0.0001 par value per share | 0.9 | 91,357.00 | 03/24/2025 Filed 2026-01-29 | SCHEDULE 13D/AAmendment 1 | Open filing 0001213900-26-009785 Dispute this row |
| Daewoong Pharmaceutical Co. Ltd ("DWP") Common Stock, $0.0001 par value per share | 0.3 | 33,334.00 | 03/24/2025 Filed 2026-01-29 | SCHEDULE 13D/AAmendment 1 | Open filing 0001213900-26-009785 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,092,408 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 1 |
| 2016 | 204,322 |
| 2017 | 202,494 |
| 2018 | 202,048 |
| 2019 | 193,638 |
| 2020 | 144,184 |
| 2021 | 224,474 |
| 2022 | 40,015 |
| 2023 | 199,811 |
| 2024 | 185,386 |
| 2025 | 235,520 |
| 2026 | 254,737 |
Filings made before the SEC required XML are listed, not extracted.